Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0GR5X
|
||||
Former ID |
DIB008800
|
||||
Drug Name |
Tolamba
|
||||
Synonyms |
AIC, Dynavax; AIC, UCB Pharma; AIC-0003; Allergy therapeutic, Dynavax; Amb a 1 ISS conjugate, Dynavax; Ragweed allergy vaccine, Dynavax; Ragweed allergy vaccine, UCB Pharma; ISS-1018 (allergy), Dynavax
|
||||
Drug Type |
Vaccine
|
||||
Indication | Allergic rhinitis [ICD9: 472.0, 477, 995.3; ICD10:J00, J30, J31.0, T78.4] | Phase 2 | [522129] | ||
Company |
Dynavax Technologies
|
||||
Target and Pathway | |||||
Target(s) | Toll-like receptor 9 | Target Info | [544095] | ||
NetPath Pathway | BCR Signaling Pathway | ||||
PANTHER Pathway | Toll receptor signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.